Second Affiliated Hospital of Fujian Medical University
In research, Second Affiliated Hospital of Fujian Medical University stands highest in Medicine (#2,422 of 10,443 worldwide), Health Sciences (#3,161 of 11,982 worldwide) and Life Sciences (#2,629 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Cancer Research and Pulmonary and Respiratory Medicine — Cancer Research is 10.9× its share of world research.
- World rank, 2022–2025
- #5,929 of 28,054 · #13,423 all time
- Rank in China
- #1,254 of 3,058
- Research works
- 1.4k ▲ 96% vs 2013–17
- Citations
- 13k 8.7 per fractional work
- Top-10% rate
- 20.3% record average 16.5%
- Open access
- 59% world 28%
What is Second Affiliated Hospital of Fujian Medical University known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #2,422 of 10,443 | 20.4% | 397 | #6256 | |
| Health SciencesDomain | #3,161 of 11,982 | 20.9% | 412 | #7714 | |
| Life SciencesDomain | #2,629 of 7,800 | 17.9% | 174 | #5953 | |
| Biochemistry, Genetics and Molecular BiologyField | #2,927 of 3,579 | 16.6% | 127 | #6071 | |
| Molecular BiologySubfield | #1,939 of 2,175 | 16.0% | 75 | #4289 |
Each strip is that field’s whole ranked pool, with the notch where Second Affiliated Hospital of Fujian Medical University sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#6,256 #2,422
- Health Sciences#7,714 #3,161
- Life Sciences#5,953 #2,629
- Biochemistry, Genetics and Molecular Biology#6,071 #2,927
- Molecular Biology#4,289 #1,939
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Second Affiliated Hospital of Fujian Medical University specialise in?
Where its research is concentrated relative to its size: Cancer Research takes 10.9× the share of its output that it takes of world research.
- Cancer ResearchSubfield · 30.3 works11×
- Pulmonary and Respiratory MedicineSubfield · 50.7 works5.1×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.7×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 3.7×
- Immunology and Microbiology 3.5×
- Medicine 3.2×
- Neuroscience 1.9×
- Pharmacology, Toxicology and Pharmaceutics 1.3×
- Nursing 1.0×
- Dentistry 0.9×
- Veterinary 0.7×
- Health Professions 0.5×
- Materials Science 0.5×
- Psychology 0.4×
- Chemistry 0.2×
- Energy 0.2×
- Environmental Science 0.2×
- Computer Science 0.2×
- Engineering 0.2×
- Agricultural and Biological Sciences 0.1×
- Decision Sciences 0.1×
- Chemical Engineering 0.1×
- Economics, Econometrics and Finance 0.1×
- Mathematics 0.1×
- Physics and Astronomy 0.0×
- Social Sciences 0.0×
- Earth and Planetary Sciences 0.0×
- Arts and Humanities 0.0×
Which keywords describe research at Second Affiliated Hospital of Fujian Medical University?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Inflammation, Epidemiology, Gene Expression, Tumor Microenvironment, Oxidative Stress, Clinical Practice Guidelines and Metastasis.
- Cancer Biomarkers
- Prognostic Markers
- Transcriptional Landscape
- RNA Regulation
- Ferroptosis
- Cell Differentiation
- Survival Analysis
- Medical Imaging
- Immunity
- Insulin Resistance
- Obesity
- Diagnosis
- Treatment
- Biogenesis
- Metastasis
- Cardiovascular Disease
- Chemotherapy
- Tumor Microenvironment
- Oxidative Stress
- Inflammation
- Cancer
- Epidemiology
- Gene Expression
- Metabolic Syndrome
- Clinical Practice Guidelines
- Biomarkers
- Management
- Cell Death
- Regulation
- Neoadjuvant Therapy
- Epigenetic Regulation
- Precision Medicine
- Neuroinflammation
- Prognostic Factors
- Radiotherapy
- Lipid Peroxidation
- GPX4
- Long Noncoding RNAs
- Cancer Progression
- Endoscopic Resection
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer70▲ 8.1×46 topics
- Inflammation63▲ 4.7×76 topics
- Epidemiology60▲ 2.4×93 topics
- Oxidative Stress40▲ 3.8×48 topics
- Gene Expression32▲ 8.3×11 topics
- Tumor Microenvironment32▲ 11×8 topics
- Metabolic Syndrome25▲ 4.8×20 topics
- Chemotherapy24▲ 5.3×21 topics
- Clinical Practice Guidelines24▲ 6.8×14 topics
- Cardiovascular Disease24▲ 3.3×31 topics
- Biomarkers23▲ 5.2×15 topics
- Metastasis21▲ 9.7×11 topics
- Management21▲ 4.1×22 topics
- Biogenesis19▲ 17×3 topics
- Cell Death19▲ 13×6 topics
- Treatment18▲ 2.4×37 topics
- Regulation18▲ 5.3×10 topics
- Diagnosis17▲ 2.9×30 topics
- Neoadjuvant Therapy16▲ 11×5 topics
- Obesity16▲ 3.3×16 topics
- Epigenetic Regulation16▲ 11×4 topics
- Insulin Resistance16▲ 5.3×10 topics
- Precision Medicine15▲ 5.2×8 topics
- Immunity14▲ 5.5×9 topics
- Neuroinflammation14▲ 7.5×6 topics
- Medical Imaging13▲ 4.0×6 topics
- Prognostic Factors13▲ 4.7×14 topics
- Survival Analysis13▲ 7.4×6 topics
- Radiotherapy13▲ 5.1×11 topics
- Cell Differentiation12▲ 21×2 topics
- Lipid Peroxidation12▲ 19×2 topics
- Ferroptosis12▲ 25×1 topic
- GPX412▲ 25×1 topic
- RNA Regulation12▲ 17×2 topics
- Long Noncoding RNAs12▲ 21×1 topic
- Transcriptional Landscape12▲ 21×1 topic
- Cancer Progression11▲ 9.5×7 topics
- Prognostic Markers10▲ 15×3 topics
- Endoscopic Resection10▲ 15×2 topics
- Cancer Biomarkers10▲ 18×3 topics
Which research topics does Second Affiliated Hospital of Fujian Medical University publish most on?
By volume in 2022–2025: Ferroptosis and cancer prognosis, Cancer-related molecular mechanisms research, MicroRNA in disease regulation and Radiomics and Machine Learning in Medical Imaging.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 12 works
- 2 Cancer-related molecular mechanisms research Cancer Research 12 works
- 3 MicroRNA in disease regulation Cancer Research 8 works
- 4 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 8 works
- 5 RNA modifications and cancer Molecular Biology 7 works
- 6 Cancer Immunotherapy and Biomarkers Oncology 7 works
- 7 Circular RNAs in diseases Molecular Biology 7 works
- 8 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 6 works
- 9 Inflammatory Biomarkers in Disease Prognosis Oncology 5 works
- 10 Extracellular vesicles in disease Molecular Biology 5 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Second Affiliated Hospital of Fujian Medical University's research output changed?
Output in 2018–2022 was 96% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Quanzhou
- Quanzhou Normal University
- Liming Vocational University
- The 180th Hospital of PLA
- Yang-En University
- Minnan University of Science and Technology
- Quanzhou Institute of Equipment Manufacturing Haixi Institute
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.